Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W (2014). NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology, 117(1):25-32.

Seidel, C; Hentschel, B; Simon, M; Schnell, O; Heese, O; Tatagiba, M; Krex, D; Reithmeier, T; Kowoll, A; Weller, M; Wick, W (2013). A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network. Journal of Neurology, 260:847-855.

Bähr, O; Hermisson, M; Rona, S; Rieger, J; Nussbaumer, S; Körtvelyessy, P; Franz, K; Tatagiba, M; Seifert, V; Weller, M; Steinbach, J P (2012). Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial. Acta Neurochirurgica, 154(2):229-235.

Roder, C; Peters, V; Kasuya, H; Nishizawa, T; Wakita, S; Berg, D; Schulte, C; Khan, N; Tatagiba, M; Krischek, B (2011). Analysis of ACTA2 in European Moyamoya disease patients. European Journal of Paediatric Neurology, 15(2):117-122.

Roder, C; Peters, V; Kasuya, H; Nishizawa, T; Takehara, Y; Berg, D; Schulte, C; Khan, N; Tatagiba, M; Krischek, B (2011). Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans. Child's Nervous System, 27(2):245-252.

Krischek, B; Kasuya, H; Khan, N; Tatagiba, M; Roder, C; Kraemer, M (2011). Genetic and clinical characteristics of Moyamoya disease in Europeans. Acta Neurochirurgica Supplementum, 112(2):31-34.

Hartmann, C; Hentschel, B; Tatagiba, M; Schramm, J; Schnell, O; Seidel, C; Stein, R; Reifenberger, G; Pietsch, T; von Deimling, A; Loeffler, M; Weller, M (2011). Molecular markers in low-grade gliomas: predictive or prognostic? Clinical Cancer Research, 17(13):4588-4599.

Weiler, M; Hartmann, C; Wiewrodt, D; Herrlinger, U; Gorlia, T; Bähr, O; Meyermann, R; Bamberg, M; Tatagiba, M; von Deimling, A; Weller, M; Wick, W (2010). Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. International Journal of Radiation Oncology, Biology and Physics, 77(3):670-676.

Roder, C; Nayak, N R; Khan, N; Tatagiba, M; Inoue, I; Krischek, B (2010). Genetics of Moyamoya disease. Journal of Human Genetics, 55(11):711-716.

Roder, C; Peters, V; Kasuya, H; Nishizawa, T; Takehara, Y; Berg, D; Schulte, C; Khan, N; Tatagiba, M; Krischek, B (2010). Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochirurgica, 152(12):2153-2160.

This list was generated on Mon Sep 23 13:30:08 2019 CEST.